{"id":1053,"date":"2014-02-10T22:46:10","date_gmt":"2014-02-10T22:46:10","guid":{"rendered":"https:\/\/blogs.bmj.com\/tc\/?p=1053"},"modified":"2014-02-10T22:46:10","modified_gmt":"2014-02-10T22:46:10","slug":"fda-moves-to-make-e-cigarette-research-more-difficult","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/","title":{"rendered":"FDA moves to make e-cigarette research more difficult"},"content":{"rendered":"

Below we republish a post<\/a> by Stan Glantz from the UCSF Center for Tobacco Control Reserved & Education.<\/p>\n

At a time when e-cigarette marketing, sales and use appears to be escalating, “real world” independent research is urgently needed. The FDA appears to be shutting down this important investigative channel.<\/p>\n

Dilbert meets Kafka again: While FDA dallies on regulating e-cigs it moves to make it harder to do meaningful research on them<\/h1>\n

by Stan Glantz<\/p>\n

Twiter: @<\/s>ProfGlantz<\/a><\/p>\n

\n

In another Dilbert meets Kafka moment<\/a>, the FDA, both directly and indirectly through NIH\/NIDA, has been telling researches that they are planning to require researchers to get an “Investigational New Drug<\/a>” (IND) approval for any studies of e-cigarettes.<\/p>\n

What this means is that, at the same time that the FDA is sitting quietly while e-cigarettes are being aggressively marketed, including with unsupported claims that they are effective smoking cessation aids<\/a> (which allows, even in the current legal environment, to regulate them as drugs right now), \u00a0and in the face of skyrocketing use by kids, \u00a0the FDA is poised to throw up roadblocks to independent research on the effects of e-cigarettes.<\/p>\n

Not only will this substantially slow down research, but it will limit the scope of what is studied.\u00a0 What we need is to understand the effects of e-cigarettes as used in the real world<\/em>, not some highly stylized “research” e-cigarettes function.<\/p>\n

Neal Benowitz has written an important letter<\/a> to Mitch Zeller, head of the FDA Center for Tobacco Products.\u00a0 His letter is worth quoting in full:<\/p>\n

I understand that the FDA is considering requiring an ITP\/IND prior to allowing federally-funded research on electronic cigarettes.\u00a0\u00a0 While such a request might make sense for e-cigarettes for which a therapeutic indication is being sought, it is a terrible idea for e-cigarette research more broadly.\u00a0 My concerns are as follows:<\/p>\n

1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The use of e-cigarettes in the U.S. population is increasing exponentially over time.\u00a0 Physicians and other health care providers and policy makers are seeking information on which to base advice for patients or the general public regarding use of e-cigarettes.\u00a0 Any delays in generating any new research data would be highly detrimental to this process.<\/p>\n

2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relatively few data are available on e-cigarettes by which to determine the risks vs. benefits of e-cigarette use in populations. Clinical and policy decisions should be made on the basis of data.<\/p>\n

3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 More than four hundred e-cigarette products are currently on the market. These have widely differing designs, including variable liquid composition, different chamber size, different batteries, different nicotine and constituent delivery, and different particulate size and distribution.\u00a0 It would be impossible to obtain the necessary data on manufacturing and safety of constituents for the various products to obtain an ITP\/IND in a timely manner, if at all.<\/p>\n

4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NIDA could develop a prototype e-cigarette for research, but this prototype would take considerable time to develop and would be limited to one or a few design characteristics.\u00a0 These limitations would result in a great delay in gaining information on e-cigarette pharmacology and safety and would have limited application to many products on the market now and in the future.<\/p>\n

5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 There are critical unanswered questions related to use patterns, nicotine delivery, addiction liability and safety that can be studied in people using their chosen e-cigarette products.\u00a0 Such research is not necessarily part of a research program to gain approval for therapeutic use.<\/p>\n

6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Requiring an ITP\/IND or NIDA e-cigarette prototype will paralyze much of the research that has been funded (or submitted for possible funding) and which is critical to inform public health.<\/p>\n

In summary, data on the addiction liability and safety of various e-cigarette products are desperately needed to inform public health decisions.\u00a0 Requiring an ITP\/IND for e-cigarettes would delay needed research and would be detrimental to public health. I strongly urge the FDA not to require an ITP\/IND for e-cigarette research, other than that intended to support application for a therapeutic indication.<\/p><\/blockquote>\n

This letter has been bouncing around among researchers who care about e-cigarettes and generated a lot of support.<\/p>\n

In response, Maciej L. Goniewicz, an Assistant Professor of Oncology in the Department of Health Behavior and the Division of Cancer Prevention and Population Sciences Roswell Park Cancer Center, who has done some of the best research on nicotine and carcinogen exposure from real e-cigarettes<\/a>, observed that<\/p>\n

For me current approach by FDA is currently blocking all my projects on >safety, toxicity and use of the products. None of this projects is a smoking cessation study. Since I got back to States I have prepared few projects and grant proposals on ecig safety. \u00a0And now FDA is paralyzing all my efforts. Recently, we got the opinion that even for \u00a0nicotine-free e-cigarettes we need IND. \u00a0We can’t monitor nicotine cravings, withdrawal system, even reduction in smoking in any of these studies because FDA claims this is “therapeutic indication”. \u00a0It looks like nowadays, the only research we can do are laboratory studies or studies on established users.<\/p><\/blockquote>\n

In short, the FDA is doing nothing to regulate e-cigarettes but is making it harder for independent researchers to collect the data needed to inform the public and policymakers (and the FDA) about the actual effects of e-cigarettes.<\/p>\n

The IND process was established to allow pharmaceutical companies who want to test drugs or make therapeutic claims about them to collect the data they need to win FDA approval for those drugs or claims.\u00a0 It would <\/em>be appropriate for the FDA to require the e-cigarette companies (and researchers they support) to go through this process.\u00a0 To date, none of the e-cigarette companies have done so.\u00a0 And, from their perspective, why bother?\u00a0 The FDA is doing nothing to regulate the therapeutic claims they are making.<\/p>\n

But it makes no sense to require investigators studying the effects of e-cigarettes on the market to go through this process.<\/p>\n

I urge other researchers who have been or will be affected by this decision to write Zeller and post their comments as replies to this blog post so that the whole community will have access to their thoughts.<\/p>\n<\/div>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Below we republish a post by Stan Glantz from the UCSF Center for Tobacco Control Reserved & Education. At a time when e-cigarette marketing, sales and use appears to be escalating, “real world” independent research is urgently needed. The FDA appears to be shutting down this important investigative channel. Dilbert meets Kafka again: While FDA […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1053","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nFDA moves to make e-cigarette research more difficult - Blog - Tobacco Control<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA moves to make e-cigarette research more difficult - Blog - Tobacco Control\" \/>\n<meta property=\"og:description\" content=\"Below we republish a post by Stan Glantz from the UCSF Center for Tobacco Control Reserved & Education. At a time when e-cigarette marketing, sales and use appears to be escalating, “real world” independent research is urgently needed. The FDA appears to be shutting down this important investigative channel. Dilbert meets Kafka again: While FDA [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog - Tobacco Control\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-10T22:46:10+00:00\" \/>\n<meta name=\"author\" content=\"BMJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BMJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/2014\\\/02\\\/10\\\/fda-moves-to-make-e-cigarette-research-more-difficult\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/2014\\\/02\\\/10\\\/fda-moves-to-make-e-cigarette-research-more-difficult\\\/\"},\"author\":{\"name\":\"BMJ\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\"},\"headline\":\"FDA moves to make e-cigarette research more difficult\",\"datePublished\":\"2014-02-10T22:46:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/2014\\\/02\\\/10\\\/fda-moves-to-make-e-cigarette-research-more-difficult\\\/\"},\"wordCount\":1020,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/2014\\\/02\\\/10\\\/fda-moves-to-make-e-cigarette-research-more-difficult\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/2014\\\/02\\\/10\\\/fda-moves-to-make-e-cigarette-research-more-difficult\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/2014\\\/02\\\/10\\\/fda-moves-to-make-e-cigarette-research-more-difficult\\\/\",\"name\":\"FDA moves to make e-cigarette research more difficult - Blog - Tobacco Control\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#website\"},\"datePublished\":\"2014-02-10T22:46:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/2014\\\/02\\\/10\\\/fda-moves-to-make-e-cigarette-research-more-difficult\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/2014\\\/02\\\/10\\\/fda-moves-to-make-e-cigarette-research-more-difficult\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/2014\\\/02\\\/10\\\/fda-moves-to-make-e-cigarette-research-more-difficult\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA moves to make e-cigarette research more difficult\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/\",\"name\":\"Blog - Tobacco Control\",\"description\":\"A space to discuss the wider issues of tobacco control beyond the journal.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#organization\",\"name\":\"Blog - Tobacco Control\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/files\\\/2017\\\/10\\\/blog-logo-tobacco-control.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/files\\\/2017\\\/10\\\/blog-logo-tobacco-control.png\",\"width\":255,\"height\":34,\"caption\":\"Blog - Tobacco Control\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\",\"name\":\"BMJ\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"caption\":\"BMJ\"},\"sameAs\":[\"https:\\\/\\\/blogs.bmj.com\\\/\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/tc\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA moves to make e-cigarette research more difficult - Blog - Tobacco Control","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/","og_locale":"en_US","og_type":"article","og_title":"FDA moves to make e-cigarette research more difficult - Blog - Tobacco Control","og_description":"Below we republish a post by Stan Glantz from the UCSF Center for Tobacco Control Reserved & Education. At a time when e-cigarette marketing, sales and use appears to be escalating, “real world” independent research is urgently needed. The FDA appears to be shutting down this important investigative channel. Dilbert meets Kafka again: While FDA [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/","og_site_name":"Blog - Tobacco Control","article_published_time":"2014-02-10T22:46:10+00:00","author":"BMJ","twitter_card":"summary_large_image","twitter_misc":{"Written by":"BMJ","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/"},"author":{"name":"BMJ","@id":"https:\/\/blogs.bmj.com\/tc\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe"},"headline":"FDA moves to make e-cigarette research more difficult","datePublished":"2014-02-10T22:46:10+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/"},"wordCount":1020,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/tc\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/","url":"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/","name":"FDA moves to make e-cigarette research more difficult - Blog - Tobacco Control","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/tc\/#website"},"datePublished":"2014-02-10T22:46:10+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/tc\/2014\/02\/10\/fda-moves-to-make-e-cigarette-research-more-difficult\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/tc\/"},{"@type":"ListItem","position":2,"name":"FDA moves to make e-cigarette research more difficult"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/tc\/#website","url":"https:\/\/blogs.bmj.com\/tc\/","name":"Blog - Tobacco Control","description":"A space to discuss the wider issues of tobacco control beyond the journal.","publisher":{"@id":"https:\/\/blogs.bmj.com\/tc\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/tc\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/tc\/#organization","name":"Blog - Tobacco Control","url":"https:\/\/blogs.bmj.com\/tc\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/tc\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/tc\/files\/2017\/10\/blog-logo-tobacco-control.png","contentUrl":"https:\/\/blogs.bmj.com\/tc\/files\/2017\/10\/blog-logo-tobacco-control.png","width":255,"height":34,"caption":"Blog - Tobacco Control"},"image":{"@id":"https:\/\/blogs.bmj.com\/tc\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/tc\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe","name":"BMJ","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","caption":"BMJ"},"sameAs":["https:\/\/blogs.bmj.com\/"],"url":"https:\/\/blogs.bmj.com\/tc\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/posts\/1053","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/comments?post=1053"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/posts\/1053\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/media?parent=1053"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/categories?post=1053"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/tc\/wp-json\/wp\/v2\/tags?post=1053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}